Astellas Venture & JIC Venture Growth in Tooth Regeneration Drug Development
02 Sep 2024
US$ 19.00
Astellas Venture Management, the US-based corporate venture arm of Japan’s Astellas Pharma Inc, has joined JIC Venture G...
Related Publications
The release of DeepSeek in January 2025 was more than just a triumphant show of China’s technological ......
Lanchi Ventures announced the final closing of its fourth dual-currency fund at US$560 m that focuses on early-stage ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.